INTRODUCTION Only a few cases of biventricular cardiogenic shock have been treated with
Impella circulatory assist devices in the United States. CLINICAL FINDINGS A 29-year-old …

Background Biventricular failure is associated with high in‐hospital mortality. Limited data
regarding the efficacy of biventricular Impella axial flow catheters (BiPella) support for …

Patients with cardiogenic shock who require mechanical circulation support may profit from
more effective, less invasive devices. Panel A shows the first-in-man use of biventricular …

Despite many advances in care, the mortality rate for cardiogenic shock remains high.
Because the medical management of patients with cardiogenic shock is limited, many …

Introduction Percutaneous mechanical circulatory support systems have increasingly been
adopted as a bail out strategy in patients with cardiogenic shock. Since studies showed …

Background Refractory cardiogenic shock (CS) entails severe systemic hypotension due to
heart dysfunction resulting in poor tissue perfusion and organ failure. Initial treatment …

We report an effective therapeutic approach of mechanical circulatory support for a patient
with cardiogenic shock and respiratory insufficiency due to fulminant myocarditis. An …

Cardiogenic shock (CS) is a state of life-threatening endorgan hypoperfusion due to
diminished cardiac output resulting from left, right, or biventricular heart failure [1, 2] …

Impella (Abiomed, Danvers, MA) is an effective option for emergent treatment of critical
refractory cardiogenic shock. However, in patients who have inadequate peripheral arterial …

Discussion Percutaneously delivered biventricular support has evolved considerably during
the past 5 years and until now has required one of the following:(1) a trans-septal puncture …